A B S T R A C T The effect of aspirin on normal and cholera toxin-stimulated electrolyte transport has been investigated in vitro, because this drug appears to inhibit cholera toxin-induced intestinal secretion in in vivo animal models. In the Ussing chamber, 10 mM aspirin decreased the control rabbit ileal potential difference and short-circuit current by 50% and increased conductance by 28%. Bidirectional electrolyte flux determinations showed that aspirin significantly increased both Na and Cl absorption and reduced the residual flux (which probably represents HCOs secretion) to zero. This effect of aspirin appears to be identical to that reported by others with catecholamines as determined with similar techniques. However, a-adrenergic blockers did not prevent the electrical effects of aspirin, suggesting that aspirin does not have its effect through release of tissue stores of catecholamines. In the presence of aspirin, cholera toxin increased the potential difference and short-circuit current, and decreased the conductance of rabbit ileum in a fashion qualitatively similar to control tissues. However, aspirin reversed cholera toxin-stimulated Na transport from secretion to absorption, inhibited cholera toxin, induced Cl secretion by 58%, and partially, but not significantly, inhibited HCOs secretion. Thus, the inhibitory effect of aspirin on cholera toxin-induced electrolyte secretion appears to be due to aspirin-stimulated Na and This work was presented in part at the American Gas-
INTRODUCTION
The hypothesis that prostaglandins might be involved in the mechanism of action of cholera toxin (1) gained support when two separate groups demonstrated that antiinflammatory drugs such as aspirin (ASA)' inhibited cholera-induced intestinal secretion (2, 3). However, subsequent reports have presented significant evidence against this hypothesis. First, it has been demonstrated that the stimulatory effects of cholera toxin and prostaglandins on intestinal adenylate cyclase activity are additive, suggesting that in the intestine there are separate receptors for these two agonists (4) . More importantly, it has been shown that ASA and indomethacin, in doses sufficient to inhibit prostaglandin synthesis, do not inhibit the stimulation of cyclic AMP (cAMP) production by cholera toxin in human leukocytes (5) or in rabbit ileal mucosa (6) . Finally, Hindi et al. have shown that cholera toxin stimulates cAMP production and intestinal secretion, but not prostaglandin synthesis, in rabbit in-'Abbreviations used in this paper: ASA, aspirin; cAMP, cyclic AMP; G, conductance; cGMP, cyclic guanosine 5'-monophosphate; I.!, short-circuit current; J, flux; m, mucosal; PD, potential difference; R, residual; s, serosal.
The Journal of Clinical Investigation Volume 57 April 1976 *916-924 testine (7) . Although these studies speak strongly against a role for prostaglandins in the secretory activity of cholera toxin, they do not explain the previously reported inhibitory action of ASA (2, 3) . The experiments reported here demonstrate this inhibitory action of ASA in vitro, and suggest that this action may be due, at least in part, to stimulatory effects of ASA on the intestinal absorptive ion-transporting mechanisms.
METHODS
All experiments were performed on the terminal ileum of 3-kg, male, New Zealand white rabbits which were not fasted. Studies were performed using a Ringer solution of the following composition, in millimoles per liter: Na, 140; K, 5.2; Ca, 1.2; Mg, 1.2; Cl, 119.8; HCO3, 25; H2PO4, 0.4; and HPO4, 2.4. Solution pH was 7.4 when bubbled with 95% 02-5%0 C02. Either mannitol or ASA was present in the solutions in 0.1-20 mM concentrations. To adjust the pH of ASA-containing solution to 7.4, they were titrated with 10 N NaOH. This added 2-4 meq/liter Na to the 10-mM ASA solutions. In cAMP experiments, the Na salt of the nucleotide was added to solutions with reduced NaCl concentration (135 mM Na, 114.8 Cl), so that the final Na and Cl concentration differed little from the basic Ringer solution. In the experiments reported here, n equals the number of animals. The significance of differences in means was tested by the paired and unpaired Student's t test, and by an analysis of variance (8) .
Electrolyte transport measurements. The methods of removing the muscle layers from the intestine, and measuring electrolyte fluxes, short-circuit current (ILe), potential difference (PD), and conductance (G) have been previously described (9) . In brief, after stripping the muscularis, four sections of terminal ileum were mounted as a flat sheet in Ussing-type chambers with apertures of 1.13 cm2. Circulating 37°C Ringer reservoirs on the mucosal (m) and serosal (s) sides of the intestine were connected to an automatic voltage clamp via Ringer-agar bridges and calomel and AgAgCl electrodes. Tissues were continuously short-circuited except for 15-s intervals every 20 min when the open-circuit PD was read. G was calculated from the PD and Lc using Ohm's law. Radioisotopes and cholera toxin were added to the bathing solutions upon stabilization of the electrical parameters (usually 10-30 min after mounting the tissues). Active cholera toxin2 was added to the mucosal solution (2 Igg/ml) of one-half the mounted tissues and heat-inactivated cholera toxin to the other tissues which served as controls. Na and Cl fluxes were measured in separate pieces of intestine. Simultaneous, bidirectional Na flux determinations were performed with 'Na and 24Na, while oppositely directed unidirectional flux rates were obtained with MCl on adjacent "pieces of intestine. Electrolyte flux measurements were performed in four conditions: 10 mM mannitolRinger without and with cholera toxin, and 10 mM ASARinger without and with cholera toxin. These four conditions are henceforth known, respectively, as the control, cholera toxin, ASA, and ASA-cholera toxin tissues. Na flux determinations were made in all four conditions at the same time on intestine from the same animals. Chloride flux rates were measured in control and cholera toxin-treated tissues in one group of animals and, in separate animals, in ASA and ASA-cholera toxin tissues. In separate studies, oppositely directed Na and Cl fluxes were measured in adjacent pieces of ileum mounted in mannitol or ASA-Ringer solution containing 7.5 mM cAMP (Sigma Chemical Co., St. Louis, Mo.) in the serosal bath and 7.5 mM mannitol in the mucosal bath. Seven 20-min flux periods were measured beginning 20 min after addition of isotopes and/or cholera toxin. Since 45-60 min are required for any cholera toxin effect, the value for each animal was derived by averaging the last three flux periods (100-160 min after cholera toxin), and the mean±SE for each group calculated from these values. In the cAMP experiments, the fluxes were derived by averaging all seven periods. The ability of aadrenergic blocking agents to inhibit ASA action was explored by determining the effect of ASA on the electrical parameters of rabbit ileum after prior incubation of the tissue with either 10 /AM phentolamine (Regitine mesylate; Ciba Pharmaceutical Co., Summit, N. J.) or 10,sM phenoxybenzamine (Dibenzyline; Smith, Kline & French, Philadelphia, Pa.).
Cyclic nucleotide measurements. Rabbit ileum was quickly removed and rinsed with ice-cold Ringer solution saturated with 95% 02-5% C02. The mucosa was separated from the underlying muscle by scraping with the edge of a glass slide, minced into small pieces, and kept cold until it was placed in the incubation solutions. Incubation solutions were the same as those used in flux studies; 10 mM mannitolRinger or ASA-Ringer, with or without cholera toxin (2) (3) (4) (5) lgg/ml). Approximately 300-500 mg of tissues was placed in each Erlenmeyer flask, gassed with 95% 02-5% C02, and continuously shaken at 100 rpm at 370C in a Dubnoff metabolic shaker. Samples of tissue for cyclic nucleotide assay were taken immediately before incubation and after 30 min, 120 min, and 180 min of incubation. Each sample was rapidly frozen in liquid nitrogen and kept at -80°C until processing. Tissue samples were then homogenized in 6% trichloroacetic acid and cyclic nucleotide content measured in triplicate by the radioimmunoassay of Steiner et al. (10) . Results 
RESULTS

Aspirin-cholera toxin studies
Electrical parameters. The effect of ASA (0.1-10 mM) on the electrical parameters (PD, I.c, and G) of rabbit ileum is shown in Fig. 1 . The PD was significantly reduced by 5 mM ASA, but a consistent effect on all the electrical parameters was not evident until 10 mM Aspirin and Intestinal Electrolyte Transport The time-course of the PD, sle, and G of rabbit ileum mounted in either 10 mM mannitol-Ringer or ASARinger, and the effect of cholera toxin on these electrical parameters in both solutions, is shown in Fig. 3 . As previously reported (12, 13) , the response of the electrical parameters to cholera toxin was a sustained increase in PD, a relatively short-lived increase in Isc and a significant reduction in G. ASA markedly depressed the PD and Ta., and increased G of rabbit ileum, but the response to cholera toxin was similar to that noted in mannitol-Ringer solution. The only demonstrable difference in the effect of cholera toxin was that a sustained increase in the T.c was elicited in ASA-Ringer. Table I summarizes the mean electrical parameters for the four conditions for the 100-160-min time period. ASA decreased the PD and TIC of rabbit ileum by 57 and 46%, FIGuRE 2 The effect of 10 mM ASA on the PD, IC,, and G of rabbit ileum when the drug is present in only the mucosal (m), serosal (s), or both (m and s) bathing solutions. The values are compared to 10 mM mannitol in paired tissues from the same animals (n = 7). The P values below the bars refer to the significance of differences between that mean±SE and the control, and the P values between bars refers to those two means. NS = not significant.
FIGURE 1
The effect of ASA, 0.1-10 mM, on the PD, Ise, and G of in vitro rabbit ileum. The means+SE are compared to 10 mM mannitol (control) in paired tissues from the same animals (n = 6). The P values below the bars refer to the significance of difference between that mean±SE and the control. NS = not significant.
ASA was employed. In separate experiments (n = 6), the effect of 20 mM ASA was examined. This high concentration often reduced the PD and the TIC to zero and greatly increased G, making it difficult to tell if the tissues were viable. Because of this, and since ASA is of limited solubility at a neutral pH, 10 toxin had no effect on JmsNt, as compared to the control, and net Na transport appears to be reversed from se- cretion (as seen in cholera toxin-treated tissues) to absorption of 0.6±0.3 ILeq/h cm2. This value was not significantly different from the control.
The effect of ASA on Cl fluxes in control and cholera toxin-stimulated ileum is very similar to that on Na flux. ASA increased both unidirectional fluxes, JmsCI greater than JsmCl, such that Jnet C was increased from 0.3±0.3 to 1.6±0.5 aeq/h cm2. In control tissues, cholera toxin caused Cl secretion, -1.2+0.2 /eq/h cm2, primarily through inhibition of Jm80c. In the presence of ASA, cholera toxin-stimulated Cl secretion appears to be inhibited by 58% (-1.2 to -0.5±0.4 ,ueq/h*cm2). This difference in JnetC' was significant at P < 0.05.
The residual flux, JnetR which represents the net ionic transport unaccounted for by the measured net Na and Cl fluxes, can be calculated by combining the Jsc from the Na and Cl experiments as follows: JnetR = Ie-(JnetNa -JnetC'). Although JnetR could represent net cation absorption or anion secretion of any charged species, there is compelling evidence in rabbit ileum that JnetR represents net HCOs secretion (14) .' ASA reduced JnetR to zero. Cholera toxin had no effect on Jnet' in mannitolRinger solution. ASA appeared to inhibit JnstR in the presence of cholera toxin by 39%, but this decrease in t Number of tissues, in parentheses. § Significance of difference between cholera toxin-and ASA-cholera toxin-treated tissues.
11 and ¶ Significance of difference between this value and the control, P < 0.001 and P < 0.05, respectively.
Adrenergic blocker studies. The effects of ASA on the electrical parameters and electrolyte fluxes in the in vitro rabbit ileum are similar to those of epinephrine as reported by Field and McColl (16) . These investigators also showed that the inhibitory effect of epinephrine on the ICe was prevented by a-adrenergic blockers, but not by P-adrenergic blockers. Since ASA's effect could be due to release of catecholamines from tissue stores, we determined the ability of a-blockers to prevent the inhibitory effect of ASA on the electrical parameters in rabbit ileum. Paired tissues were incubated for 30 min in mannitol-Ringer solution in the presence or absence of 10lM phenoxybenzamine or phentolamine. The mannitol-Ringer was then replaced by ASA-Ringer (with or without the blocker) and the electrical parameters followed for an additional hour. As shown in Fig. 4 , phenoxybenzamine did not prevent the inhibitory effect of ASA on the TIC of rabbit ileum. In fact, as was also true with phentolamine (n = 3), the ASA inhibition of TIC (and PD) was greater in the tissue-pair incubated with the a-blocker.
Cyclic nucleotide studies. Since ASA's action could involve cyclic nucleotides, tissue cAMP and cGMP concentrations were measured after incubation under the same four conditions as electrolyte fluxes were measured: control, ASA, cholera toxin, and ASA-cholera toxin (Fig. 5) . Cholera toxin significantly increased cAMP concentrations at 120 and 180 min of incubation as compared to controls (P < 0.001). ASA reduced cAMP levels in both unstimulated (P < 0.05) and cholera toxinstimulated (P < 0.01) tissues. Neither ASA nor cholera toxin had any effect on tissue cGMP concentrations.
The ability of ASA to inhibit cAMP-stimulated electrolyte secretion was further studied by the simultaneous measurement of Na and Cl fluxes in paired tissues secreting in response to exogenously added cAMP (Table  III) . The secretory rate in these tissues was several-fold greater than that induced by cholera toxin (Table II) !.
Nevertheless, ASA reduced the secretory rates of Na, Cl, and HCO3 (JnetR) by approximately 50%. In absolute terms, the ASA-induced change in net electrolyte flux 'The secretory response to cAMP reported here was somewhat greater than that reported previously from this laboratory (13) or by others (17, 18) , and probably represents biological variability among different animal populations. was greater in the cAMP studies than in the cholera toxin studies. For example, the ASA-induced change in JnetNa was (-) 3.5 -(-) 6.5 = 3.0 in the cAMP group and only 0.6 -(-) 0.4 = 1.0 Aeq/h cm' in the cholera toxin group. DISCUSSION Although the previously cited studies (4-7) essentially rule out a role for prostaglandins as a link between cholera toxin and the resulting diarrhea, it is clear from experiments in vivo (2, 3) , and the present experiments in vitro, that ASA inhibits cholera toxin-stimulated intestinal secretion and stimulates electrolyte absorption in normal intestine. An inhibitory effect of ASA on intestinal secretion of other types has been noted previously in studies of spontaneous secretion from canine duodenal pouches (19) . In addition, other anti-inflammatory and with cholera toxin (El). cAMP concentrations were significantly greater than control values after 120-180-min incubation with cholera toxin (P <0.001). ASA is significantly different from control (P <0.05), and ASAcholera toxin is significantly different from cholera toxin (P < 0.01) at 120 and 180 min also. There was no significant difference in cGMP concentrations between the tissues incubated in any of the four conditions. drugs, such as indomethacin, have been shown to inhibit cholera-, salmonella-, or shigella-mediated intestinal secretion (20, 21) . Our investigation gives some insight into the possible mechanism of action of these anti-inflammatory drugs. In Fig. 6 are summarized the directions and magnitudes of net transport of Na, Cl, and Juet' (HCOs) in control, ASA, cholera toxin, and ASAcholera toxin-treated intestine. ASA promotes solute (and presumably water) absorption in rabbit intestine by markedly stimulating net Na and C1 absorption and inhibiting HCO3 secretion. Cholera toxin's effect is essentially the opposite-it stimulates Na and C1 secretion both in vitro and in vivo, and in vivo it stimulates HCOs secretion as well. When cholera toxin is given together with ASA, the resulting pattern of transport appears to be the algebraic sum of the opposing absorptive and secretory action of these two agents. In addition, although the cholera toxin-induced changes in the electrical parameters of the in vitro rabbit ileum were somewhat different in ASA-Ringer as compared to mannitol-Ringer (Fig. 3) , the PD and Isc were stimulated by cholera toxin in both instances. Together, these points suggest that the inhibitory effect of ASA on cholera toxin-stimulated secretion is simply one of stimulated absorption superimposed on continued secretion. In this respect it would be similar to the effect of intraluminal glucose on cholera toxin-stimulated secretion. However, as discussed below, it is also possible that ASA has its effect through inhibition of cAMP-mediated secretory mechanisms. ASA has a significant effect on intestinal transport in normal tissues. First, ASA significantly decreased the PD and Isc of in vitro rabbit ileum by approximately 50%, and increased G by 28%. This effect of ASA is similar to that noted by Kasbekar in the in vitro gastric mucosa (21, 22) . However, in intestine, in spite of this seemingly noxious effect, the active m to s transport of both Na and Cl were significantly stimulated. The reduction in PD and Ic might be secondary to an inhibition of electrogenic HCOs secretion, since the residual flux, which probably represents HCO3 secretion, was reduced to zero by ASA. However, there is controversy regarding the rheogenicity of HCO3 secretion in the rabbit ileum (17, 23, 24) . Therefore, the ASA effect on PD and Iae may be due to inhibition of other rheogenic ion transport processes. Another significant difference between the gastric and intestinal response to ASA in vitro is that ASA is significantly more effective and its action irreversible when added to the m bath of the gastric preparation. In intestine, ASA is more effective when added to the s bath and the effect on intestine also seems to be partially reversible by changing the bathing solution to ASA-free Ringer. One of the most intriguing aspects regarding the present results is the striking resemblance between the effect of ASA and the effect of catecholamines on the normal, in vitro rabbit ileum. As reported by Field et al. (16, 18) in studies with techniques essentially identical to those used here, epinephrine and norepinephrine inhibited the PD and Lc, increased G, stimulated Na and Cl absorption, and reduced JnetB (HCO8 secretion) to zero. The mechanism of the effect of these a-adrenergic drugs is unclear at present (18) . An obvious explanation for the mechanism of ASA's action could be that ASA has adrenergic activity or that it releases catecholamines from terminal sites in the intestinal mucosa. There is no precedent for the first explanation, in that ASA does not have adrenergic activity when tested in other systems (25) . In addition, we have been unable to block the ASA effect on the electrical parameter with a-adrenergic blockers which do block these catecholamine effects in rabbit ileum (16, 18) . This suggests that the effect of ASA on ion transport is distal to the site where a-adrenergic drugs enter this chain of events. ASA may work directly on the cell membranes or the ion-transporting pumps. Such an action of salicylate has been reported in the erythrocyte (26, 27) and nervous tissues (28) . Alternatively, as discussed below, ASA's effect could involve cAMP-mediated mechanisms.
In spite of evidence suggesting that ASA's absorptive effects are independent from cholera toxin's secretory action, it is possible that the secretory and absorptive processes of rabbit ileum are closely interrelated. Nellans et al. (29) and Schultz and Curran (30) have suggested that the brush border-located, coupled NaCl influx mechanism of rabbit ileum (31) responds to changes in intracellular cAMP concentrations by either NaCl (HCOs) absorption or NaCl (HCOa) secretion. If this were true then the ASA (and catecholamines) effects could still involve cyclic nucleotides. Indeed, ASA reduced cAMP levels in normal tissue and inhibited the increase in tissue cAMP concentrations brought about by cholera toxin. These data, alone, would suggest that an inhibition of adenylate cyclase or a stimulation of phosphodiesterase by ASA reduced cellular cAMP concentrations which, in turn, inhibited secretion and/or stimulated absorption. Although this might be the case, our additional experiments with exogenous cAMP suggest that this alone cannot be the explanation of ASA's mechanism of action. Thus, ASA inhibited the Na and anion secretion induced by exogenously added cAMP, a condition where tissue production or degradation of cyclic nucleotides are less likely to be a limiting factor. Therefore, if ASA's effect involves a cAMP-mediated system, ASA might well operate at a step distal to cAMP production or degradation. The cAMP-protein kinase or protein kinase-electrolyte pump steps could be the locus of ASA's action. The effect of ASA on cholera toxininduced intestinal secretion then becomes similar, from the point of view of the possible mechanisms involved, to the ASA inhibition of cAMP-induced lipolysis in fat cells (32) (33) (34) . In this model system. Schdnh6fer et al. (33) and Dinnendahl et al. (34) have shown that salicylates decrease cAMP levels in fat cells but the more important effect seems to be inhibition of a cAMP-dependent protein kinase. These issues will need to be clarified in the case of ASA inhibition of cholera toxin action of the intestine.
Whether ASA is effective in the treatment of the diarrhea of cholera will have to be determined by trials in man. A tolerable blood level of ASA in man is 2-3 mM, which is somewhat lower than the effective dose in our in vitro studies. The data in Fig. 2 suggest that the blood concentration, rather than luminal concentration, would be important for the intestinal effect. Whether useful in the treatment of cholera or not, investigation of the mechanism of action of this drug might give important insight into the mechanism of electrolyte transport in normal intestine and into other possible therapeutic modalities for the treatment of diarrheas due to intestinal secretion.
